The impossible task of developing a new treatment for heart failure.
Packer
Milton
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D004864:Equipment and Supplies / Q000592:standards; D006333:Heart Failure / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D016730:Program Development; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D014481:United States
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D011945:Receptors, Angiotensin